892 filings
8-K
XOMA
XOMA Corp
3 Apr 24
Completion of Acquisition or Disposition of Assets
9:27am
SC TO-T/A
KNTE
Kinnate Biopharma Inc
3 Apr 24
Third party tender offer statement (amended)
9:06am
ARS
2023 FY
XOMA
XOMA Corp
2 Apr 24
Annual report to shareholders
7:50am
DEFA14A
XOMA
XOMA Corp
2 Apr 24
Additional proxy soliciting materials
7:40am
DEF 14A
XOMA
XOMA Corp
Definitive proxy
2 Apr 24
7:31am
SC TO-T/A
KNTE
Kinnate Biopharma Inc
19 Mar 24
Third party tender offer statement (amended)
4:44pm
S-4
XOMA
XOMA Corp
Registration of securities issued in business combination transactions
11 Mar 24
6:56am
S-3
XOMA
XOMA Corp
Shelf registration
8 Mar 24
4:34pm
10-K
2023 FY
XOMA
XOMA Corp
Annual report
8 Mar 24
7:47am
8-K
XOMA
XOMA Corp
8 Mar 24
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
7:39am
SC TO-T
KNTE
Kinnate Biopharma Inc
4 Mar 24
Third party tender offer statement
5:24pm
SC TO-C
KNTE
Kinnate Biopharma Inc
27 Feb 24
Information about tender offer
4:42pm
8-K
XOMA
XOMA Corp
16 Feb 24
XOMA Enters into Agreement to Acquire Kinnate Biopharma
9:08am
SC 13G/A
XOMA
XOMA Corp
9 Feb 24
XOMA / FMR ownership change
10:05am
SC 13D/A
XOMA
XOMA Corp
16 Jan 24
XOMA / BIOTECHNOLOGY VALUE FUND L P ownership change
5:22pm
8-K
XOMA
XOMA Corp
11 Jan 24
Departure of Directors or Certain Officers
4:31pm
4
Owen Hughes
10 Jan 24
XOMA / Owen Hughes ownership change
4:30pm
8-K
XOMA
XOMA Corp
2 Jan 24
XOMA Announces Stock Repurchase Program of up to $50 Million
7:46am
8-K
XOMA
XOMA Corp
19 Dec 23
Proceeds expected to be used for stock repurchases and additional royalty and milestone acquisitions
7:40am
10-Q
2023 Q3
XOMA
XOMA Corp
Quarterly report
7 Nov 23
7:40am